Business

Novo Nordisk Restructures for Obesity Market

Updated 2026-09-14 07:25 UTC 1 source Neutral

Novo Nordisk rebranded to 'Novo' and announced corporate changes as it competes in the obesity market. The company faces stiff competition from Eli Lilly.

Coverage timeline — 1 article

CNBC

Novo Nordisk rebrands to 'Novo,' unveils corporate changes as it fights for obesity market share

The Danish drugmaker called the changes the beginning of a new chapter for the company, which faces stiff competition from Eli Lilly.

2026-09-14 07:00 UTC